South Africa will begin providing lenacapavir on June 5 after delays tied to postimportation testing, while Uganda has launched rollout of the twice-yearly HIV prevention injection in Lira.
South Africa is working to identify local manufacturers for lenacapavir, a twice-yearly injectable HIV prevention drug that showed near-perfect efficacy in clinical trials. Kenya has already received 21,000 doses of the medication.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05663502 |
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers |
RECRUITING | |
| NCT00221754 |
Pravastatin and Protease Inhibitors in HIV-infected Patients |
COMPLETED | PHASE2 |
